Virus tethering selenium molecule

Selenium's Hidden Role: How Viruses Like Ebola and HIV Could Be Hijacking Your Body's Defenses

Reese Marlowe in Health & Wellness December 2025 • 4 min read.

"New research reveals a surprising link between viral infections and selenium, suggesting viruses might be manipulating our cells to thrive."

For years, scientists have understood that viruses are masters of manipulation, subtly altering our cellular functions to replicate and spread. One area of increasing interest is how viruses interact with our body's non-coding RNAs, influencing everything from mRNA degradation to ribosomal translation.

A new study has proposed a groundbreaking idea: viruses may be engaging in 'antisense tethering interactions' (ATIs). This means they could be capturing functional RNA motifs from our cells, specifically to tether the mRNAs of selenoproteins. Selenoproteins are crucial for various biological processes, and viruses could be exploiting them for their own benefit.

This research explores how certain RNA viruses might use this strategy to gain additional protein-coding potential. By capturing a selenocysteine insertion sequence (SECIS) element, viruses could potentially express virally-encoded selenoprotein modules, translating in-frame UGA stop codons as selenocysteine. The findings suggest that this mechanism might impact host selenium biochemistry during infections like Ebola and HIV-1.

The Selenium-Virus Connection: What the Science Says

The study dives deep into the potential for viruses to 'hijack' selenoproteins. Researchers used computational analysis to predict thermodynamically stable ATIs between widely expressed mammalian selenoprotein mRNAs (like isoforms of thioredoxin reductase) and specific Ebola virus mRNAs, as well as HIV-1 mRNA. These interactions were further validated through DNA gel shift assays.

What makes these ATIs particularly intriguing is their location. In both Ebola and HIV-1, these interactions are found in close proximity to highly conserved in-frame UGA stop codons at the 3' end of open reading frames. These frames encode essential viral proteins, such as the HIV-1 nef protein and the Ebola nucleoprotein.

Ebola's Evolutionary Shift: The study points out that the 2014 Ebola strain shows a better antisense match to human TR3 compared to the 1976 strain, suggesting a possible adaptation from bats to humans.
HIV's Selenium Link: Research has consistently shown an inverse correlation between serum selenium levels and mortality in HIV/AIDS patients. Selenium supplementation has also demonstrated clinical benefits.
Antioxidant Defense: Encoding an antioxidant selenoprotein could help viruses withstand the body's immune responses, increasing their survival and ability to spread.

These findings suggest that viruses might be manipulating the host's selenium biochemistry to their advantage. Whether it's through antisense inhibition of cellular selenoprotein synthesis or direct competition for selenocysteine, the implications are significant.

What This Means for the Future

This research opens up exciting new avenues for understanding how viruses interact with our bodies. If ATIs are indeed functionally significant, it could change how we approach treatments for viral infections, especially those like Ebola and HIV. Further research is needed to fully understand the multifaceted role of selenium in virus-host interactions and its clinical significance.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.2174/1568026615666150915121633, Alternate LINK

Title: Cellular Selenoprotein Mrna Tethering Via Antisense Interactions With Ebola And Hiv-1 Mrnas May Impact Host Selenium Biochemistry

Subject: Drug Discovery

Journal: Current Topics in Medicinal Chemistry

Publisher: Bentham Science Publishers Ltd.

Authors: Ethan Will Taylor, Jan A. Ruzicka, Lakmini Premadasa, Lijun Zhao

Published: 2016-03-01

Everything You Need To Know

How might viruses like Ebola and HIV affect our body's defenses?

Viruses like Ebola and HIV might be manipulating our body's defenses by engaging in 'antisense tethering interactions' (ATIs). This involves capturing functional RNA motifs from our cells, specifically to tether the mRNAs of selenoproteins. Selenoproteins are crucial for various biological processes, which viruses could be exploiting for their own benefit.

Why are selenoproteins important, and how do viruses exploit them?

Selenoproteins are vital for various biological processes. These proteins contain selenium, which plays a key role in antioxidant defense. By exploiting selenoproteins through 'antisense tethering interactions' (ATIs), viruses can potentially express virally-encoded selenoprotein modules, helping them withstand the body's immune responses, increasing their survival and ability to spread.

What is the mechanism by which viruses might hijack selenoproteins?

The study suggests that viruses can use a mechanism called 'antisense tethering interactions' (ATIs). This means viruses can capture selenocysteine insertion sequence (SECIS) elements, enabling them to express virally-encoded selenoprotein modules. This mechanism allows viruses to translate in-frame UGA stop codons as selenocysteine, impacting host selenium biochemistry during infections like Ebola and HIV-1.

What is the significance of selenium in Ebola and HIV infections?

The research indicates that the 2014 Ebola strain shows a better antisense match to human TR3 compared to the 1976 strain. Also, research consistently shows an inverse correlation between serum selenium levels and mortality in HIV/AIDS patients. This highlights the importance of selenium in the context of these viral infections and suggests a possible adaptation of the virus to human hosts, and the potential benefit of selenium supplementation.

What are the implications of this research for future treatments?

If 'antisense tethering interactions' (ATIs) are functionally significant, it could change how we approach treatments for viral infections, particularly Ebola and HIV. Further research is needed to fully understand the multifaceted role of selenium in virus-host interactions and its clinical significance. The study opens up new avenues for understanding how viruses interact with our bodies, potentially leading to new therapeutic strategies.